KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Profit After Tax (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Profit After Tax readings, the most recent being $369.0 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 72.43% to $369.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 billion, a 214.07% increase, with the full-year FY2025 number at $1.4 billion, up 171.98% from a year prior.
  • Profit After Tax hit $369.0 million in Q1 2026 for Teva Pharmaceutical Industries, down from $480.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $480.0 million in Q4 2025 to a low of -$1.3 billion in Q4 2022.
  • Median Profit After Tax over the past 5 years was -$253.0 million (2023), compared with a mean of -$195.5 million.
  • Biggest five-year swings in Profit After Tax: crashed 1336.36% in 2022 and later skyrocketed 274.55% in 2025.
  • Teva Pharmaceutical Industries' Profit After Tax stood at -$1.3 billion in 2022, then skyrocketed by 134.58% to $461.0 million in 2023, then plummeted by 159.65% to -$275.0 million in 2024, then skyrocketed by 274.55% to $480.0 million in 2025, then dropped by 23.12% to $369.0 million in 2026.
  • The last three reported values for Profit After Tax were $369.0 million (Q1 2026), $480.0 million (Q4 2025), and $433.0 million (Q3 2025) per Business Quant data.